Global Condyloma Acuminatum Drugs Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Condyloma Acuminatum Drugs Market Research Report 2024
Condyloma acuminatum (also known as genital warts, acuminata, papilloma acuminatum) is a sexually transmitted infection caused by the human papillomavirus (HPV) that primarily affects the genital area and surrounding skin. Drug treatments for genital warts include the following types
Acid medicationsYour doctor may recommend some acid medications, such as citric acid, trichloroacetic acid, or salicylic acid, to help remove the wart. These medications cause the wart to gradually dry out, die off and fall off.
Immunomodulatory drugsSome drugs boost the activity of the local immune system to help the body fight viruses. These drugs include Imiquimod, which, when applied topically, prompts immune cells to release interferon, which inhibits viral growth.
According to Mr Accuracy reports’s new survey, global Condyloma Acuminatum Drugs market is projected to reach US$ 2464.6 million in 2029, increasing from US$ 1787 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Condyloma Acuminatum Drugs market research.
Factors such as rising prevalence of sexually transmitted diseases (STDs) and human papillomavirus infections along with growing male population are expected to further drive the overall growth of the genital warts treatment market over the forecast period.
In addition, the effectiveness of topical administration of lamiquimod can be enhanced by concomitant use of IL-10 inhibitors, attracting more T cells and destroying HPV-infected keratinocytes of genital warts, thereby causing a stronger effect than vaccination. response to treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Condyloma Acuminatum Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bausch Health Companies Inc
Merck & Co., Inc
Taro Pharmaceutical Industries Ltd
CryoIQ
GSK Plc
BioNTech SE
Serum Institute of India Pvt。Ltd
Fotona
Orgenesis Inc
Perrigo Company plc
PerkinElmer Inc
Bio-Rad Laboratories, Inc.
Abbvie Inc
Phio Pharmaceuticals Corp
Teva Pharmaceutical Industries Ltd
Emblation Ltd
Segment by Type
Oral Medicine
External Drugs
Hospital
Specialist Clinic
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Condyloma Acuminatum Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Acid medicationsYour doctor may recommend some acid medications, such as citric acid, trichloroacetic acid, or salicylic acid, to help remove the wart. These medications cause the wart to gradually dry out, die off and fall off.
Immunomodulatory drugsSome drugs boost the activity of the local immune system to help the body fight viruses. These drugs include Imiquimod, which, when applied topically, prompts immune cells to release interferon, which inhibits viral growth.
According to Mr Accuracy reports’s new survey, global Condyloma Acuminatum Drugs market is projected to reach US$ 2464.6 million in 2029, increasing from US$ 1787 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Condyloma Acuminatum Drugs market research.
Factors such as rising prevalence of sexually transmitted diseases (STDs) and human papillomavirus infections along with growing male population are expected to further drive the overall growth of the genital warts treatment market over the forecast period.
In addition, the effectiveness of topical administration of lamiquimod can be enhanced by concomitant use of IL-10 inhibitors, attracting more T cells and destroying HPV-infected keratinocytes of genital warts, thereby causing a stronger effect than vaccination. response to treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Condyloma Acuminatum Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch Health Companies Inc
Merck & Co., Inc
Taro Pharmaceutical Industries Ltd
CryoIQ
GSK Plc
BioNTech SE
Serum Institute of India Pvt。Ltd
Fotona
Orgenesis Inc
Perrigo Company plc
PerkinElmer Inc
Bio-Rad Laboratories, Inc.
Abbvie Inc
Phio Pharmaceuticals Corp
Teva Pharmaceutical Industries Ltd
Emblation Ltd
Segment by Type
Oral Medicine
External Drugs
Segment by Application
Hospital
Specialist Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Condyloma Acuminatum Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices